Results 151 to 155 of about 868 (155)

Abstract No. 129: Next Generation Radioembolization Device (TheraSphere-EX): Results from a 13 Patient Pilot Study

Journal of Vascular and Interventional Radiology, 2008
R.K. Lewandowski, S.M. Ibrahim, R.K. Ryu, R.A. Omary, R. Salem   +4 more
openaire   +1 more source

Abstract No. 35: Quality assurance and safety of Y-90 glass microsphere (TheraSphere) therapy: A systematic, site-specific approach

Journal of Vascular and Interventional Radiology, 2010
J.W. Pinchot, M. Martz, R. Hieb, E.J. Hohenwalter, R. Hellman, E. Bancud, W.S. Rilling   +6 more
openaire   +1 more source

A RETROSPECTIVE ANALYSIS ON OBJECTIVE TUMOUR RESPONSE IN PATIENTS TREATED WITH RADIOEMBOLIZATION FOR UNRESECTABLE PRIMARY AND METASTATIC LIVER CANCER WITH YTTRIUM – 90 MICROSPHERES (THERASPHERE)

2013
Naidoo S, Kotzen J, Duvern Ramiah, Sanyika C, F, Daniels, T, Van Rooyen, Nosworthy A, Ruff P, Ramos J, Vangu M   +9 more
openaire   +1 more source

TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Case Medical Research
exaly  

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Case Medical Research
exaly